股票 › ABUS
阿布图斯生物制药 ABUS
美股市值排名 #3432
$3.66 −$0.02 (-0.41%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $3.65 -0.14%
开盘$3.65
昨收$3.67
当日区间$3.62 – $3.75
成交量1.72M
市值$724.08M
市盈率（TTM）4.6
股息率–
ABUS 相关新闻
匹配 Arbutus Biopharma 或代码 ABUS 的头条新闻，按最新排序。
- Arbutus Biopharma: Arbutus Biopharma Corporation - Broker-To-Broker Settlement/Exercise Considerations Option Symbol: ABUS
- Arbutus Biopharma: Arbutus Biopharma Corporation - Partial Self Tender Offer Option Symbol: ABUS
- Earnings Flash (ABUS) Arbutus Biopharma Posts Q1 EPS $0.87, Vs. FactSet Est of $0.03 Loss 负面
- Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Total Revenue $14.1M, Vs. FactSet Est of $13.6M
- Earnings Flash (ABUS) Arbutus Biopharma Posts 2025 Loss $0.17 a Share, Vs. FactSet Est of $0.19 Loss 负面
- ABUS Stock Has Given up Its Prior Gain. Arbutus Biopharma Shares Were Trading Higher After the Company Presented Clinical Trial Data From Its Two HBV Assets. 正面
- JMP Securities Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $5
- Earnings Flash (ABUS) Arbutus Biopharma Corporation Reports Q3 Revenue $529,000, Vs. FactSet Est of $1.3M
- H.C. Wainwright Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $5
- Jefferies Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $7 正面
- Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Maintains Target Price $4
- JMP Securities Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5 正面
- Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $4.5 正面
- Chardan Capital Maintains Arbutus Biopharma(ABUS.US) With Buy Rating, Raises Target Price to $5 正面
- H.C. Wainwright Keeps Their Buy Rating on Arbutus Biopharma (ABUS)
暂无评论——快来第一个聊聊 ABUS。
登录后参与讨论。